Unlock stock picks and a broker-level newsfeed that powers Wall Street.
HKSE - Delayed Quote HKD

Honliv Healthcare Management Group Company Limited (9906.HK)

Compare
1.540
+0.010
+(0.65%)
At close: March 18 at 9:39:14 AM GMT+8
Loading Chart for 9906.HK
  • Previous Close 1.530
  • Open 1.540
  • Bid 1.500 x --
  • Ask --
  • Day's Range 1.540 - 1.540
  • 52 Week Range 1.500 - 2.540
  • Volume 2,000
  • Avg. Volume 255,540
  • Market Cap (intraday) 910.199M
  • Beta (5Y Monthly) 0.17
  • PE Ratio (TTM) 22.00
  • EPS (TTM) 0.070
  • Earnings Date Mar 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Honliv Healthcare Management Group Company Limited engages in the ownership, operation, and management of hospitals in the People's Republic of China. The company provides integrated medical and pharmaceutical services, and hospital management services. The company also operates as the pharmaceutical wholesaler. In addition, it operates and manages Henan Honliv Hospital. The company was founded in 2004 and is headquartered in Changyuan, China. Honliv Healthcare Management Group Company Limited is a subsidiary of Sunny Rock Capital Limited.

www.honlivhp.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 9906.HK

View More

Performance Overview: 9906.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

9906.HK
25.96%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

9906.HK
39.13%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

9906.HK
26.67%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

9906.HK
40.77%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 9906.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 9906.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    910.20M

  • Enterprise Value

    814.79M

  • Trailing P/E

    20.56

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.03

  • Price/Book (mrq)

    1.51

  • Enterprise Value/Revenue

    0.95

  • Enterprise Value/EBITDA

    13.58

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.05%

  • Return on Assets (ttm)

    3.24%

  • Return on Equity (ttm)

    5.59%

  • Revenue (ttm)

    768.72M

  • Net Income Avi to Common (ttm)

    31.15M

  • Diluted EPS (ttm)

    0.070

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    258.5M

  • Total Debt/Equity (mrq)

    30.41%

  • Levered Free Cash Flow (ttm)

    -25.79M

Research Analysis: 9906.HK

View More

Company Insights: 9906.HK

Research Reports: 9906.HK

View More

People Also Watch